By Test Type
- Traditional Diagnostic Tests
- RIDT
- Viral Culture
- DFA
- Serological Assays
- Molecular Diagnostic Tests
- RT-PCR
- INNAT
- TMA
- LAMP
- NASBA
- Other INNAT
- Other Molecular Tests
By End User
- Hospitals
- Point of Care Laboratories
- Laboratories
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
The market is categorised into test type, end user and region. The test type segment is fragmented into traditional diagnostic test and molecular diagnostic tests. The molecular diagnostic test segment is divided into reverse transcription polymerase chain reaction (RT-PCR), INNAT while the traditional diagnostic tests segment is further divided into rapid influenza diagnostic test (RIDT), DFA, viral culture, serological assays. The RIDT segment is predicted to hold the largest influenza diagnostics market share and this is mainly owing to its capability of det4cting influenza type B and A in specimens. This test is considered as a benchmark for influenza diagnostics as it can provide results within 30 minutes, thereby increasing its popularity among patients. On the other hand, the RT-PCR is expected to proliferate with a substantial growth rate during the forecast period. RT-CPR test can deliver results in 20 minutes or it may even take 2 hours, depending on the kind of case. These tests can detect both nonviable and viable influenza virus. Furthermore, the chances of obtaining false positive or negative results are very low in these tests, thereby making it more reliable than other forms of tests. However, the RT-PCR test is expensive when compared to other tests for diagnosing influenza which can impede the growth of this segment.
The end user segment is fragmented into laboratories, point of care labs and hospitals. The hospital segment dominated the market, but it is the point of care diagnostic labs that are predicted to subjugate the market during the forecast period owing to the increased accuracy in the results provided by these laboratories as compared to hospitals. Furthermore, it is easy to use, and it does not require any medical expertise, except understanding the basic operations. The physician and the public are more reliant on these tests owing to their accuracy, thus boosting the growth of this segment.
The North America region is expected to lead the market owing to several initiatives undertaken by the government in creating awareness regarding the diagnosis and treatment of influenza. Additionally, technological advancements along with increased healthcare expenditure is predicted to boost the growth of the market in the region. However, the Asia Pacific region is anticipated to grow rapidly during the forecast period and this is due to a rise in the population density and increasing geriatric population in the region.